Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in agerelated macular degeneration (AMD)

International Journal of Biochemistry and Molecular Biology

Volumn 3, Issue 1, 2012, Pages 105-116

  Lukiw, Walter J ^a   Surjyadipta, Bhattacharjee ^a   Dua, Prerna ^b   Alexandrov, Peter N ^c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA TECH UNIVERSITY   (United States)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Brain; Complement factor H; Evolution; Micro RNA; miRNA regulatory control (MIRC) region; miRNA 125b; miRNA 146a; miRNA 155; miRNA 9; Retina; Small non coding RNA

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 125B; MICRORNA 146A; MICRORNA 155; MICRORNA 9; RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; BINDING AFFINITY; BINDING SITE; BRAIN TISSUE; COMPLEMENT FACTOR H GENE; DOWN REGULATION; DRUSEN; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; REGULATOR GENE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; REVIEW; SENILE PLAQUE; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84859702614     PISSN: None     EISSN: 21524114     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. http://www.preventblindness.org/ resources/visiondata. html; http://www.nei.nih.gov/health/ maculardegen/ armdfacts.asp.
2. Zipfel PF, Lauer N, Skerka C. The role of comple-ment in AMD. Adv Exp Med Biol 2010; 703: 9-24.
3. Donoso LA, Vrabec T, Kuivaniemi H. The role of complement Factor H (CFH) in age-related macu-lar degeneration: a review. Surv Ophthalmol 2010; 55: 227-246.
4. Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS. Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol 2010; 128: 349-358.
5. Kondo N, Bessho H, Honda S, Negi A. Comple-ment factor HY402H variant and risk of age-related macular degeneration in Asians: a sys-tematic review and meta-analysis. Ophthalmol-ogy 2011; 118: 339-344.
6. Takata K, Kitamura Y. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β peptides, and microglia in Alzheimer's disease. J Pharmacol Sci 2012; [Epub ahead of print].
7. Cui JG, Hill JM, Zhao Y, Lukiw WJ. Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease. Neuroreport 2007; 18: 115-119.
8. Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog Retina Eye Res 2011; 30: 217-238.
9. Alexandrov PN, Pogue AI, Bhattacharjee S, Lukiw WJ. Retinal amyloid-beta and complement factor H expression in transgenic models of Alz-heimer's disease. Neuroreport 2011; 22: 623-627.
10. Chiu K, Chan TF, Wu A, Leung IY, So KF, Chang RC. Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina? Age (Dordr) 2011; [Epub ahead of print].
11. Kaarniranta K, Salminen A, Haapasalo A, Soin-inen H, Hiltunen M. Age-related macular degen-eration (AMD): Alzheimer's disease in the eye? J Alzheimers Dis 2011; 24: 615-631.
12. Cui JG, Kuroda H, Chandrasekharan NV, Pelaez RP, Simmons DL, Bazan NG, Lukiw WJ. Cyclooxy-genase-3 gene expression in Alzheimer hippo-campus and in stressed human neural cells. Neurochem Res 2004; 29: 1731-1737.
13. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006; 26: 10129-10140.
14. Li YY, Cui JG, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ. Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse mod-els. Neuroscience Letters 2011; 487: 94-98.
15. Fletcher EL, Jobling AI, Vessey KA, Luu C, Guy-mer RH, Baird PN. Animal models of retinal dis-ease. Prog Mol Biol Transl Sci 2011; 100: 211-286.
16. Li YY, Cui JG, Dua P, Pogue AI, Bhattacharjee S, Lukiw WJ. Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci-ence Letters 2011; 499: 109-113.
17. Dutescu RM, Li QX, Crowston J, Masters CL, Baird PN, Culvenor JG. Amyloid precursor protein processing and retinal pathology in mouse mod-els of Alzheimer's disease. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1213-1221.
18. Ramkumar HL, Zhang J, Chan CC. Retinal ultra-structure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res 2010; 29: 169-190.
19. Zeiss CJ. Animals as models of age-related macular degeneration: an imperfect measure of the truth. Vet Pathol 2010; 47: 396-413.
20. Telander DG. Inflammation and age-related macular degeneration (AMD). Semin. Ophthal-mol 2011; 26: 192-197.
21. Lukiw WJ, Dua P, Pogue AI, Eicken C, Hill JM. Up-regulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler Scheinker (GSS) syn-drome. Journal of Toxicology and Environmental Health 2011; 74: 1460-1468.
22. Pogue AI, Percy ME, Cui JG, Li YY, Bhattacharjee S, Hill JM, Kruck TPA, Zhao Y, Lukiw WJ. Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures. J Inorganic Biochem 2011; 105: 1434-1437.
23. Lukiw WJ, Zhao Y, Cui JG. An NF-kB-sensitive micro RNA-146a-mediated inflammatory circuitin Alzheimer disease and in stressed human neural cells. J Biol Chem 2008; 283: 31315-31322.
24. Li YY, Alexandrov PN, Pogue AI, Zhao Y, Bhat-tacharjee S, Lukiw WJ. miRNA-155 up-regulation and complement factor H (CFH) deficits in Down's Syndrome. Neuroreport 2012; 23: 168-173.
25. Lukiw WJ, Alexandrov PN. Regulation of comple-ment factor H (CFH) by multiple miRNAs in Alz-heimer's disease brain. Molecular Neurobiology 2012; Epub ahead of print].
26. Pasluosta CF, Dua P, Lukiw WJ. Nearest hyper-plane distance neighbor clustering algorithm applied to gene co-expression analysis in Alz-heimer's disease, Proceedings of the IEEE Engi-neering in Medicine and Biology Society. EMBS 2011; 6091344: 5559-5562.
27. Chen M, Forrester JV, Xu H. Synthesis of comple-ment factor H (CFH) by retinal pigment epithelial cells is down-regulated by oxidized photorecep-tor outer segments. Exp Eye Res 2007; 84: 635-645.
28. Kociok N, Joussen AM. Enhanced expression of the complement factor H (CFH) mRNA in prolifer-ating human RPE cells. Graefes Arch Clin Exp Ophthalmol 2010; 248: 1145-1153.
29. Ding JD, Johnson LV, Herrmann R, Farsiu S, Smith SG, Groelle M, Mace BE, Sullivan P, Jami-son JA, Kelly U, Harrabi O, Bollini SS, Dilley J, Kobayashi D, Kuang B, Li W, Pons J, Lin JC, Bowes Rickman C. Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macu-lar degeneration. Proc Natl Acad Sci USA 2011; 108: 279-287.
30. Prakasam A, Muthuswamy A, Ablonczy Z, Greig NH, Fauq A, Rao KJ, Pappolla MA, Sambamurti K. Differential accumulation of secreted βAPP metabolites in ocular fluids. J Alzheimers Dis 2010; 20: 1243-1253.
31. Lukiw WJ. NF-kB-regulated micro RNAs (miRNAs) in primary human brain and retinal cells. Exp Neurol 2011; [Epub ahead of print].
32. Barile GR, Schmidt AM. RAGE and its ligands in retinal disease. Curr Mol Med 2007; 7: 758-765.
33. Zetterberg M, Landgren S, Andersson ME, Palmér MS, Gustafson DR, Skoog I, Minthon L, Thelle DS, Wallin A, Bogdanovic N, Andreasen N, Blennow K, Zetterberg H. Association of comple-ment factor H Y402H gene polymorphism with Alzheimer's disease. Am J Med Genet B Neuro-psychiatr Genet 2008; 147: 720-726.
34. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian miRNAs act to decrease target mRNA levels. Nature 2010; 466: 835-840.
35. Wang LL, Huang Y, Wang G, Chen SD. The poten-tial role of microRNA-146 in Alzheimer's disease: Biomarker or therapeutic target? Medical Hy-potheses 2012; 78: 398-401.
36. Jiang M, Xiang Y, Wang D, Gao J, Liu D, Liu Y, Liu S, Zheng D. Dysregulated expression of miRNA-146a contributes to age-related dysfunction of macrophages. Aging Cell 2012; 11: 29-40.
37. Xu D, Sharma C, Hemler ME. Tetraspanin 12 regulates ADAM10-dependent cleavage of amy-loid precursor protein. FASEB J 2009; 23: 3674-3681.
38. Junge HJ, Yang S, Burton JB, Paes K, Shu X, French DM, Costa M, Rice DS, Ye W. TSPAN12 regulates retinal vascular development by pro-moting Norrin-but not Wnt-induced FZD4/beta-catenin signaling. Cell 2009; 139: 299-311.
39. Chan LW. Modeling equilibrium of microRNA Expression. Front Genet 2011; 2: 35.
40. Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc) 2007; 72: 578-582.
41. Lukiw WJ, Pogue AI. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem 2007; 101: 1265-1269.
42. Sethi P, Lukiw WJ. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 2009; 459: 100-104.
43. Yuva-Aydemir Y, Simkin A, Gascon E, Gao FB. MicroRNA-9: functional evolution of a conserved small regulatory RNA. RNA Biol 2011; 8: 557-564.
44. Liao JL, Yu J, Huang K, Hu J, Diemer T, Ma Z, Dvash T, Yang XJ, Travis GH, Williams DS, Bok D, Fan G. Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum Mol Genet 2010; 19: 4229-4238.
45. Cui JG, Li YY, Zhao Y, Bhattacharjee S, Lukiw WJ. Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by mi-croRNA-146a and NF-kB in stressed human astroglial cells. J Biol Chem 2010; 285: 38951-38960.
46. Zhao Y, Calon F, Julien C, Winkler JW, Petasis NA, Lukiw WJ, Bazan NG. Docosahexaenoic acid-derived neuroprotectin D1 (NPD1) induces neu-ronal survival via secretase-and PPARγ-mediated mechanisms in Alzheimer's disease models. PLoS One 2011; 6: e15816.
47. Atwood CS, Martins RN, Smith MA, Perry G. Se-nile plaque composition and post-translational modification of amyloid-beta peptide and associ-ated proteins. Peptides 2002; 23: 1343-1350.
48. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 2002; 99: 14682-14687.
49. Wang L, Li CM, Rudolf M, Belyaeva OV, Chung BH, Messinger JD, Kedishvili NY, Curcio CA. protein particles of intraocular origin in human Bruch membrane: an unusual lipid profile. Invest Ophthalmol Vis Sci 2009; 50: 870-877.
50. Rudolf M, Clark ME, Chimento MF, Li CM, Medeiros NE, Curcio CA. Prevalence and mor-phology of druse types in the macula and periph-ery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci 2008; 49: 1200-1209.
51. Jung T, Catalgol B, Grune T. The proteasomal system. Mol Aspects Med 2009; 30: 191-296.
52. Hebert DN, Bernasconi R, Molinari M. ERAD sub-strates: which way out? Semin Cell Dev Biol 2010; 21: 526-532.
53. Decembrini S, Bressan D, Vignali R, Pitto L, Mariotti S, Rainaldi G, Wang X, Evangelista M, Barsacchi G, Cremisi F. MicroRNAs couple cell fate and developmental timing in retina. Proc Natl Acad Sci USA 2009; 106: 21179-21184.
54. Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, Redmond TM. Inflammatory cyto-kines regulate microRNA-155 expression in hu-man retinal pigment epithelial cells by activating JAK/STAT pathway. Biochem Biophys Res Com-mun 2010; 402: 390-395.
55. Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010; 38: 7248-7259.
56. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003-5008.
57. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L, Tamassia N, Mantovani A, Cas-satella MA, Locati M. Induction and regulatory function of miR-9 in human monocytes and neu-trophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 2009; 106: 5282-5287.
58. Shibata M, Nakao H, Kiyonari H, Abe T, Aizawa S. MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J Neurosci 2011; 31: 3407-3422.
59. Kutty RK, Samuel W, Jaworski C, Duncan T, Nagi-neni CN, Raghavachari N, Wiggert B, Redmond TM. microRNA expression in human retinal pig-ment epithelial (ARPE-19) cells: increased ex-pression of microRNA-9 by N-(4-hydroxyphenyl) retinamide. Mol Vis 2010; 16: 1475-1486.
60. Arora A, Guduric-Fuchs J, Harwood L, Dellett M, Cogliati T, Simpson DA. Prediction of microRNAs affecting mRNA expression during retinal devel-opment. BMC Dev Biol 2010; 10: 1.
61. Bonev B, Pisco A, Papalopulu N. MicroRNA-9 reveals regional diversity of neural progenitors along the anterior-posterior axis. Dev Cell 2011; 20: 19-32.
62. Zhang Z, Chang H, Li Y, Zhang T, Zou J, Zheng X, Wu J. MicroRNAs: potential regulators involved in human anencephaly. Int J Biochem Cell Biol 2010; 42: 367-374.
63. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 2004; 5: R13.
64. Pogue AI, Cui JG, Li YY, Zhao Y, Culicchia F, Lukiw WJ. miRNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neuro-sci Lett 2010; 476: 18-22.
65. Feng J, Kim ST, Liu W, Kim JW, Zhang Z, Zhu Y, Berens M, Sun J, Xu J. An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma. Cancer 2011; 118: 232-240.
66. Hennig R, Kehl T, Noor S, Ding XZ, Rao SM, Berg-mann F, Fürstenberger G, Büchler MW, Friess H, Krieg P, Adrian TE. 15-lipoxygenase-1 production is lost in pancreatic cancer and over-expression of the gene inhibits tumor cell growth. Neoplasia 2007; 9: 917-926.
67. Yao PJ, Zhu M, Pyun EI, Brooks AI, Therianos S, Meyers VE, Coleman PD. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 2003; 12: 97-109.
68. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-κB-dependent induction of miRNA-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486.
69. Saba R, Gushue S, Huzarewich RL, Manguiat K, Medina S, Robertson C, Booth SA. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune re-sponse and the microglial activation state. PLoS One 2012; 7: e30832.
70. Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, van Vliet EA, Baayen JC, Gorter JA. Expression pattern of miRNA-146a, an inflammation-associated microRNA, in experimental and hu-man temporal lobe epilepsy. Eur J Neurosci 2010; 31: 1100-1107.
71. Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, Feldman RD, Chakrabarti S. miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 2011; 60: 2975-2984.
72. Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Hooks JJ, Redmond TM. Inflammatory cyto-kines regulate microRNA-155 expression in hu-man retinal pigment epithelial cells by activating JAK/STAT pathway. Biochem Biophys Res Com-mun 2010; 402: 390-395.
73. Lukiw WJ, Ottlecz A, Lambrou G, Grueninger M, Finley J, Thompson HW, Bazan NG. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci 2003; 44: 4163-4170.
74. Kovacs B, Lumayag S, Cowan C, Xu S. MicroR-NAs in early diabetic retinopathy in streptozoto-cin-induced diabetic rats. Invest Ophthalmol Vis Sci 2011; 52: 4402-4409.
75. Lukiw WJ, Mukherjee PK, Cui JG, Bazan NG. A2E selectively induces COX-2 in ARPE-19 and hu-man neural cells. Curr Eye Res 2006; 31: 259-263.
76. Hébert SS, De Strooper B. Alterations of the mi-croRNA network cause neurodegenerative disease. Trends in Neuroscience 2009; 32: 199-206.
77. Tsitsiou E, Lindsay MA. microRNAs and the im-mune response. Curr Opin Pharmacol 2009; 9: 514-520.
78. Maiorano NA, Hindges R. Non-Coding RNAs in Retinal Development. Int J Mol Sci 2012; 13: 558-578.
79. Xu S. Micro RNA expression in the eyes and their significance in relation to functions. Prog Retin Eye Res 2009; 28: 87-116.
80. Karali M, Peluso I, Gennarino VA, Bilio M, Verde R, Lago G, Dollé P, Banfi S. Mirneye: a micro RNA expression atlas of the mouse eye. BMC Genomics 2010; 11: 715.
81. Roy S, Sen CK. MiRNA in innate immune re-sponses: novel players in inflammation. Physiol Genomics 2011; 43: 557-565.